Positive News SentimentPositive NewsNASDAQ:SAVA Cassava Sciences (SAVA) Earnings Date, Estimates & Call Transcripts $16.80 +0.16 (+0.96%) (As of 10/2/2023 ET) Add Compare Share Share Today's Range$16.40▼$17.0350-Day Range$16.64▼$21.9852-Week Range$16.40▼$46.29Volume678,023 shsAverage Volume947,312 shsMarket Capitalization$705.10 millionP/E RatioN/ADividend YieldN/APrice Target$54.33 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateNov. 6EstimatedActual EPS (Aug. 3) -$0.63 Missed By -$0.05 Consensus EPS (Aug. 3) -$0.58 Get Cassava Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for SAVA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSAVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SAVA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Cassava Sciences Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20232($0.72)($0.35)($0.54)Q2 20233($0.81)($0.39)($0.59)Q3 20233($0.90)($0.42)($0.71)Q4 20233($1.14)($0.41)($0.82)FY 202311($3.57)($1.57)($2.66)SAVA Earnings Date and InformationCassava Sciences last posted its earnings results on August 3rd, 2023. The reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.05. Cassava Sciences has generated ($2.19) earnings per share over the last year (($2.19) diluted earnings per share). Earnings for Cassava Sciences are expected to grow in the coming year, from ($3.27) to $0.16 per share. Cassava Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off prior year's report dates.Read More Cassava Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 11/6/2023Estimated)------- 8/3/2023Q2 2023($0.58)($0.63)($0.05)($0.63)--5/1/2023Q1 2023($0.56)($0.58)($0.02)($0.58)--2/28/2023Q4 2022($0.58)($0.47)+$0.11($0.47)--11/7/2022Q3 2022($0.47)($0.51)($0.04)($0.51)--8/3/2022Q2 2022($0.42)($0.48)($0.06)($0.48)--5/5/2022Q1 2022($0.43)($0.44)($0.01)($0.44)-- Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2/28/2022Q4 2021($0.41)($0.35)+$0.06($0.35)-- 11/10/2021Q3 2021($0.15)($0.24)($0.09)($0.24)--8/3/2021Q2 2021($0.13)($0.13)-($0.13)-- 4/20/2021Q1 2021($0.10)($0.09)+$0.01($0.09)--3/22/2021Q4 2020($0.05)($0.09)($0.04)($0.09)--11/9/2020Q3 2020($0.07)($0.06)+$0.01($0.06)-- Cassava Sciences Earnings - Frequently Asked Questions When is Cassava Sciences's earnings date? Cassava Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off last year's report dates. Learn more on SAVA's earnings history. Did Cassava Sciences beat their earnings estimates last quarter? In the previous quarter, Cassava Sciences (NASDAQ:SAVA) missed the analysts' consensus estimate of ($0.58) by $0.05 with a reported earnings per share (EPS) of ($0.63). Learn more on analysts' earnings estimate vs. SAVA's actual earnings. How much profit does Cassava Sciences generate each year? Cassava Sciences (NASDAQ:SAVA) has a recorded net income of -$76.25 million. SAVA has generated -$2.19 earnings per share over the last four quarters. What is Cassava Sciences's EPS forecast for next year? Cassava Sciences's earnings are expected to grow from ($3.27) per share to $0.16 per share in the next year. More Earnings Resources from MarketBeat Related Companies: POINT Biopharma Global Earnings Arcturus Therapeutics Earnings Vera Therapeutics Earnings Collegium Pharmaceutical Earnings Travere Therapeutics Earnings Avid Bioservices Earnings Kura Oncology Earnings Verve Therapeutics Earnings Cogent Biosciences Earnings Pharming Group Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CarMax Slides On Earnings Disappointment, Time To Celebrate?5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 EarningsDoes Ciena's Earnings Beat Signal New Networking Boom Ahead?The 5 Most Upgraded Stocks From Q2 Earnings Reporting SeasonNordstrom: 3 Reasons the Pre-Earnings Dip Is an OpportunityWhat Ross Stores Earnings Say About The Saver Shopping Economy3 Ways To Trade, Trade Desk Stock Post Earnings This page (NASDAQ:SAVA) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.